Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClinigen Share News (CLIN)

Share Price Information for Clinigen (CLIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 629.00
Bid: 626.00
Ask: 627.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.16%)
Open: 640.00
High: 644.50
Low: 624.00
Yest. Close: 631.50
CLIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Synairgen Progresses Covid-19 Treatment As Expenses Increase

29 Sep 20 12:14

Clinigen Ups Final Dividend After Seeing Profit Almost Double

Clinigen Ups Final Dividend After Seeing Profit Almost Double

17 Sep 20 11:40

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

16 Sep 20 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

10 Sep 20 16:01

Thursday broker round-up

(Sharecast News) - Stagecoach Group: Peel Hunt upgrades to buy with a target price of 70.0p.

23 Jul 20 14:25

Clinigen Annual Profit Rise To Be At Lower End Of Guidance

Clinigen Annual Profit Rise To Be At Lower End Of Guidance

14 Jul 20 11:04

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

14 Jul 20 09:49

Clinigen FY revenues continue to rise, profit growth slowed by Covid-19

(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its Foscavir drug.

14 Jul 20 09:07

Clinigen gets orphan drug designation for 'aldesleukin' in the US

(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for 'aldesleukin', in the treatment of amyotrophic lateral sclerosis (ALS).

13 Jul 20 16:29

Monday broker round-up

(Sharecast News) - Kingfisher: RBC Capital Markets reiterates outperform with a target price of 275.0p

13 Jul 20 13:48

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin

13 Jul 20 08:41

Sunday newspaper round-up: Two meters, Rolls Royce, Clinigen

(Sharecast News) - Senior scientists have reported flaws in an influential World Health Organization-commissioned study into the risks of coronavirus infection and say it should not be used as evidence for relaxing the UK's 2-metre physical distancing rule. Critics of the distancing advice, which states that people should keep at least 2 metres apart, believe it is too cautious. They seized on the research commissioned by the WHO, which suggested a reduction from 2 metres to 1 would raise infection risk only marginally, from 1.3% to 2.6%. - Guardian

14 Jun 20 19:22

Thursday broker round-up

(Sharecast News) - Provident Financial: RBC Capital Markets reiterates sector performer with a target price of 195p.

28 May 20 13:34

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

UK BROKER RATINGS SUMMARY: Jefferies Initiates Greggs, Games Workshop

28 May 20 09:37

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

26 May 20 17:50

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.